Jun 04, 2025
13:10
For every 10 shares held, investors received 13. The price per share adjusted from $22.56 to $17.35.
The split itself did not change the total investment value.
Pacific Shuanglin Bio-pharmacy Co., Ltd. Class A (SZSE:000403) operates in the Biotechnology industry.
Pacific Shuanglin Bio-pharmacy Co., Ltd. Class A company overviewPacific Shuanglin Bio-pharmacy Co., Ltd. Class A's most recent stock split was on June 4, 2025. It was a 13-for-10 forward split, so shareholders received 13 shares for every 10 they held.
Pacific Shuanglin Bio-pharmacy Co., Ltd. Class A (SZSE:000403) has split its stock 5 times: a 8-for-5 split on January 10, 1997, a 3-for-2 split on September 5, 2000, a 8-for-5 split on February 8, 2013, a 1303-for-726 split on July 27, 2020, and a 13-for-10 split on June 4, 2025.
Pacific Shuanglin Bio-pharmacy Co., Ltd. Class A has split its stock 5 times. This history records 5 forward splits between January 10, 1997 and June 4, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Pacific Shuanglin Bio-pharmacy Co., Ltd. Class A's 13-for-10 split on June 4, 2025, every 10 shares became 13 shares.
Pacific Shuanglin Bio-pharmacy Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on June 4, 2025, 1 year ago. Companies announce splits in advance, and any new SZSE:000403 split will appear on this page.
Already premium?